Since the launch of the Hong Kong laboratory in July 2025, Omics Empower has supported research teams with local single-cell sequencing and spatial transcriptomics services. Faster processing helps preserve RNA integrity and cell viability, supporting high-quality single-cell data generation.

Xenium™, developed by 10x Genomics, enables direct detection and quantification of RNA within intact tissue while preserving tissue architecture, achieving single-cell and subcellular resolution. Omics Empower is the second laboratory in Hong Kong to operate the Xenium platform, further expanding local availability of high-resolution in situ spatial transcriptomics for applications including oncology, neuroscience, immunology, and translational research.

In addition to Xenium™, the Hong Kong laboratory also supports 10x Genomics Visium for whole-transcriptome spatial profiling, as well as Stereo-seq, developed by BGI Group. Together, these platforms cover a range of resolution and tissue-scale needs, allowing research teams to select the best approach based on study design and sample characteristics.

With local single-cell and spatial capabilities in Hong Kong, Omics Empower will continue to expand its regional footprint and support life science and multi-omics research across Asia-Pacific.

About Omics Empower

Omics Empower is a leading global life science service provider focused on cutting-edge technologies including single-cell sequencing and spatial transcriptomics. With a laboratory network across the U.S., Europe, and Asia, Omics Empower supports cross-regional coordination and project delivery for research teams worldwide. To date, Omics Empower has supported 500+ peer-reviewed publications in single-cell and spatial omics, including studies published in Nature, Science, and Cell.